Coronavirus

Generative AI May Accelerate Drug Discovery for COVID Antivirals

June 29, 2023 - Researchers have developed a generative artificial intelligence (AI) model capable of designing novel molecules to block SARS-CoV-2, the virus that causes COVID-19, according to a study published in Science Advances last week. Drug discovery is often a long, challenging process, the researchers noted, particularly when the structure of drug-target...

Read More


More Articles

ML Highlights Population Differences in Long COVID Risk, Symptoms

by Shania Kennedy

Researchers from Weill Cornell Medicine using machine learning (ML)-based analysis of electronic health record (EHR) data found that long COVID risk and symptoms present differently across diverse...

AI Can Interpret At-Home COVID-19 Tests, Aid Viral Illness Diagnoses

by Shania Kennedy

George Mason University researchers have highlighted how artificial intelligence (AI) can help in the diagnosis of COVID-19 through a series of five papers published in the Journal of Quality...

Mobile Apps Leverage Artificial Intelligence to Monitor COVID-19, COPD

by Mark Melchionna

Research from the Maastricht University Institute of Data Science and the University of Bristol described new mobile apps that are using artificial intelligence (AI) features, such as voice analytics...

Florida Researchers to Use AI to Track Coronavirus Variants

by Mark Melchionna

To help address the ongoing pandemic, researchers from the University of Florida (UF) are using funding from the school to remain ahead of coronavirus variants through the creation of an artificial...

ML Models Can Help Optimize COVID-19 Hospital Admission Decisions

by Shania Kennedy

A new study published this month in npj Digital Medicine shows the positive impact of the multisite implementation of a workflow-integrated machine-learning (ML) system to predict short-term risk and...

NY Health Consortium Receives $8M to Expand Patient Data Network

by Shania Kennedy

The Patient-Centered Outcomes Research Institute (PCORI) has awarded nearly $8 million to expand the INSIGHT Clinical Research Network, a Weill Cornell-led database containing EHR and clinical trial...

“All of Us” Program Expands COVID-19, SDOH Data Available to Researchers

by Shania Kennedy

The National Institutes of Health’s (NIH) All of Us Research Program has announced that health data from 20,000 people who have had SARS-CoV-2 is now available to researchers in the US, expanding...

Natural Language Processing Helps Shed Light on Youth Mental Health Crisis

by Shania Kennedy

American youth have been battling high anxiety and grief amid the COVID-19 pandemic, according to a new report. The Crisis Text Line, a nonprofit organization that provides free, 24/7 text-based...

NIH Awards $68M to AI Company as Part of Antiviral Drug Development Collab

by Shania Kennedy

The National Institutes of Health (NIH) have announced that PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, has been awarded $68 million as part of the...

New Framework to Evaluate Bias in COVID-19 Prediction Models

by Shania Kennedy

Researchers have developed a framework to evaluate and address unrecognized modeling bias that can be present in healthcare-related artificial intelligence (AI). According to a study published in...

Mayo, CDC Leaders: Policy, Coalitions Key Barriers to Data Modernization

by Shania Kennedy

To prepare for the next pandemic, healthcare leaders believe that data modernization is key, but several challenges stand in the way, including conflicting policies, lack of interoperability, and the...

CDC to Expand Wastewater Monitoring for COVID-19 Through Analytics Collab

by Shania Kennedy

The Centers for Disease Control and Prevention (CDC) and wastewater epidemiology company Biobot Analytics have announced a partnership to expand the National Wastewater Surveillance System (NWSS),...

Risk Models Show Vital Signs, Age Linked to COVID-19 Severity

by Mark Melchionna

While researching the correlation between COVID-19 and health outcomes, a study published in Scientific Reports used risk models to discover that vital signs, lab results, and age are factors that...

Deep Learning Model Able to Detect Emotion Related to COVID-19

by Shania Kennedy

A new study published in Applied Soft Computing found that the content of emergency response phone calls could be analyzed and classified by a deep learning model based on emotion detection, and then...

Wearable Sensors Can Detect COVID-19

by Mark Melchionna

While reviewing strategies for detecting and managing COVID-19, a recent study found that wearable sensors that monitor heart rate, skin temperature, and respiratory rate showed promise. Researchers...

High Social Vulnerability Linked to High Rates of COVID-19 Mortality

by Mark Melchionna

When comparing groups that experienced the worst effects of COVID-19, a study published in Public Health Nursing found that the pandemic had a significant impact on those who exhibit high social...

New Machine Learning Tool Can Help Predict COVID-19 Death Risk

by Mark Melchionna

Researchers from Yale University developed the multiscale PHATE machine learning tool that provides a detailed analysis of millions of immune cells and information regarding which type could lead to...

New Model Helps Predict COVID-19 Patient Deterioration

by Mark Melchionna

Throughout the COVID-19 pandemic, providers realized that predicting clinical deterioration among patients is an important step to take, a new study published in The BMJ shows. During the pandemic,...

Machine Learning Can Help Predict Severe COVID-19

by Mark Melchionna

Machine learning techniques can be used to predict the severity of COVID-19, thereby enabling providers to optimize care, a study from Infectious Diseases of Poverty shows. The study included 287...

Recent Articles